Trypanosoma cruzi P21: a potential novel target for chagasic cardiomyopathy therapy-Reference-Cited by-同舟云学术

Trypanosoma cruzi P21: a potential novel target for chagasic cardiomyopathy therapy

Published:2015-11-17 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Teixeira Thaise Lara,Machado Fabrício Castro,Alves da Silva Aline,Teixeira Samuel Cota,Borges Bruna Cristina,dos Santos Marlus Alves,Martins Flávia Alves,Brígido Paula Cristina,Rodrigues Adele Aud,Notário Ana Flávia Oliveira,Ferreira Bruno Antônio,Servato João Paulo Silva,Deconte Simone Ramos,Lopes Daiana Silva,Ávila Veridiana Melo Rodrigues,Araújo Fernanda de Assis,Tomiosso Tatiana Carla,Silva Marcelo José Barbosa,da Silva Claudio Vieira

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep16877.pdf

Reference63 articles.

1. Carvalho, A. C. C. et al. Cell therapy in Chagas Disease. Interd. Perspc. Infect. Dis. 2009, 1–6 (2009).

2. Abuhad, A., Segre, C. A. W., Demarchi, L. M. M. F. & Aiello, V. Case 06/2005 –progressive heart failure in a 65-year-old man with permanent cardiac pacemaker. Arq. Bras.Ccardiol. 85, 437–443 (2005).

3. Ramírez, J. D. et al. Chagas Cardiomyopathy Manifestations and Trypanosoma cruzi Genotypes Circulating in Chronic Chagasic Patients. PLoS. Negl. Trop. Dis. 4, e899, doi: 10.1371/journal.pntd.0000899 (2010).

4. Ferrer, M. F., Pascuale, C. A. & Gomez, R. M. DTU I isolates of Trypanosoma cruzi induce upregulation of Galectin-3 in murine myocarditis and fibrosis. Parasitol. 141, 849–858 (2014).

5. Cruz-Robles, D. et al. Association between IL-1B and IL-1RN gene polymorphisms and Chagas’ disease development susceptibility. Immunol. Invest. 38, 231–239 (2009).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Trypanosoma cruzi pleiotropic protein P21 orchestrates the intracellular retention and in-vivo parasitism control of virulent Y strain parasites;Frontiers in Cellular and Infection Microbiology;2024-06-26

2. Trypanosoma cruzi P21 recombinant protein modulates Toxoplasma gondii infection in different experimental models of the human maternal–fetal interface;Frontiers in Immunology;2023-10-16

3. Antitumor Mechanisms of Molecules Secreted by Trypanosoma cruzi in Colon and Breast Cancer: A Review;Anti-Cancer Agents in Medicinal Chemistry;2023-09

4. Parasitomimetics: Can We Utilize Parasite-Derived Immunomodulatory Molecules for Interventions to Immunological Disorders?;Frontiers in Immunology;2022-03-21

5. Ablation of the P21 Gene of Trypanosoma cruzi Provides Evidence of P21 as a Mediator in the Control of Epimastigote and Intracellular Amastigote Replication;Frontiers in Cellular and Infection Microbiology;2022-02-18